•Risk for thrombosis in patients with cancer and AF is more heterogeneous, but certain cancer types (pancreatic, breast, uterine) and somatic mutations (anaplastic lymphoma kinase rearrangements in lung cancer, etc) may have an increased risk compared with patients without cancer. Here, ALK is linked to cancer.